Showing results (71-80 of 529) with videos related to
Sort By:
Pageof 53
Urology|March 1, 1996
Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapyC S Wu, A Pollack, B Czerniak, et al.International Journal of Radiation Oncology, Biology, Physics|July 15, 1997
Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiationD L Joon, M Hasegawa, C Sikes, et al.Cancer|July 15, 1993
Prostate-specific antigen. An important marker for prostate cancer treated by external beam radiation therapyG K Zagars, A C von EschenbachJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2000
Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancerA Pollack, G K Zagars, L G Smith, et al.Cancer|May 15, 1993
Primary carcinoma of the female urethra. Results of radiation therapyA S Garden, G K Zagars, L DelclosUrology|March 1, 1995
Frequency and characterization of p53 mutations in clinically localized prostate cancerM C Hall, N M Navone, P Troncoso, et al.The Journal of Urology|January 1, 1990
Preoperative irradiation and radical cystectomy for stages T2 and T3 squamous cell carcinoma of the bladderD A Swanson, A Liles, G K ZagarsCancer Research|June 15, 1997
Quiescence in R3327-G rat prostate tumors after androgen ablationA Pollack, D L Joon, C S Wu, et al.Cancer|June 1, 1993
Dedifferentiation of locally recurrent prostate cancer after radiation therapy. Evidence for tumor progressionJ A Wheeler, G K Zagars, A G AyalaRadiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 1, 1987
An explanatory hypothesis for early- and late-effect parameter values in the LQ modelT E Schultheiss, G K Zagars, L J PetersPageof 53